Catherine Brézault

3.3k total citations · 1 hit paper
54 papers, 2.3k citations indexed

About

Catherine Brézault is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Catherine Brézault has authored 54 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 14 papers in Surgery. Recurrent topics in Catherine Brézault's work include Colorectal Cancer Treatments and Studies (17 papers), Gastric Cancer Management and Outcomes (14 papers) and Hepatocellular Carcinoma Treatment and Prognosis (11 papers). Catherine Brézault is often cited by papers focused on Colorectal Cancer Treatments and Studies (17 papers), Gastric Cancer Management and Outcomes (14 papers) and Hepatocellular Carcinoma Treatment and Prognosis (11 papers). Catherine Brézault collaborates with scholars based in France, Switzerland and United States. Catherine Brézault's co-authors include Benoît Terris, Stanislas Chaussade, Olivier Soubrane, Laura Rubbia‐Brandt, Gilles Mentha, B. Dousset, Vincent Audard, P. Sartoretti, A. Roth and Philippe Morel and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Surgery.

In The Last Decade

Catherine Brézault

52 papers receiving 2.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer

2004 772 citations Laura Rubbia‐Brandt, Vincent Audard et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine Brézault France	19	1.6k	1.3k	590	482	341	54	2.3k
Johannes Scheele Germany	17	1.2k 0.8×	1.4k 1.1×	984 1.7×	455 0.9×	211 0.6×	28	2.1k
Pierre Balladur France	27	2.1k 1.3×	2.2k 1.7×	1.8k 3.1×	746 1.5×	279 0.8×	80	3.4k
Hironori Kaneko Japan	33	1.5k 0.9×	1.7k 1.3×	1.6k 2.7×	881 1.8×	382 1.1×	163	3.2k
Axel Andrès Switzerland	28	1.9k 1.2×	2.0k 1.5×	1.9k 3.1×	625 1.3×	291 0.9×	93	3.5k
Catherine Julié France	27	1.7k 1.1×	550 0.4×	697 1.2×	629 1.3×	169 0.5×	69	2.4k
Klaus Kaczirek Austria	27	861 0.5×	597 0.5×	983 1.7×	406 0.8×	431 1.3×	76	2.1k
Myrddin Rees United Kingdom	19	1.2k 0.8×	1.2k 0.9×	865 1.5×	404 0.8×	225 0.7×	40	1.9k
Hiroshi Takamori Japan	28	1.3k 0.8×	686 0.5×	1.1k 1.9×	632 1.3×	585 1.7×	155	2.6k
Yasuhiko Nagano Japan	31	1.1k 0.7×	1.1k 0.8×	1.2k 2.1×	951 2.0×	473 1.4×	104	2.5k
Atsushi Nanashima Japan	26	685 0.4×	1.1k 0.9×	1.2k 2.0×	758 1.6×	618 1.8×	210	2.6k

Countries citing papers authored by Catherine Brézault

Since Specialization

Citations

This map shows the geographic impact of Catherine Brézault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Brézault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Brézault more than expected).

Fields of papers citing papers by Catherine Brézault

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Brézault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Brézault. The network helps show where Catherine Brézault may publish in the future.

Co-authorship network of co-authors of Catherine Brézault

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Brézault. A scholar is included among the top collaborators of Catherine Brézault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Brézault. Catherine Brézault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cottereau, Anne‐Ségolène, et al.. (2021). Indications of Peptide Receptor Radionuclide Therapy (PRRT) in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors: An Updated Review. Journal of Clinical Medicine. 10(6). 1267–1267. 33 indexed citations

Palmieri, Lola‐Jade, et al.. (2020). Medical Treatment of Advanced Pancreatic Neuroendocrine Neoplasms. Journal of Clinical Medicine. 9(6). 1860–1860. 7 indexed citations

Ali, Einas Abou, Arthur Belle, Sarah Leblanc, et al.. (2020). Organ Preservation after Endoscopic Resection of Early Esophageal Cancer with a High Risk of Lymph Node Involvement. Cancers. 12(12). 3598–3598. 4 indexed citations

Palmieri, Lola‐Jade, Einas Abou Ali, Anne‐Ségolène Cottereau, et al.. (2019). Non-Pharmacological Therapeutic Options for Liver Metastases in Advanced Neuroendocrine Tumors. Journal of Clinical Medicine. 8(11). 1907–1907. 13 indexed citations

Barret, Maximilien, Sarah Leblanc, Marion Dhooge, et al.. (2018). Impact of a dedicated multidisciplinary meeting on the management of superficial cancers of the digestive tract. SHILAP Revista de lepidopterología. 6(12). E1470–E1476. 2 indexed citations

Dior, Marie, Diane Damotte, Johann Dréanic, et al.. (2017). Immune Checkpoint Inhibitor-Induced Colitis: Diagnosis and Management. Targeted Oncology. 12(3). 301–308. 65 indexed citations

Brieau, Bertrand, et al.. (2017). Tumour growth increased following antiangiogenic interruption. Anti-Cancer Drugs. 28(9). 1062–1065. 2 indexed citations

Dréanic, Johann, et al.. (2016). Gastric Carcinoma at the Era of Targeted Therapies. Current Drug Targets. 17(15). 1818–1826. 3 indexed citations

Brieau, Bertrand, Maximilien Barret, Alexandre Rouquette, et al.. (2015). Resection of Late Pulmonary Metastases from Pancreatic Adenocarcinoma: Is Surgery an Option?. Cancer Investigation. 33(10). 522–525. 13 indexed citations

10.

Grégory, Thomas, Marion Dhooge, Catherine Brézault, et al.. (2015). Long term exposure to antiangiogenic therapy, bevacizumab, induces osteonecrosis. Investigational New Drugs. 33(5). 1144–1147. 12 indexed citations

11.

Mir, Olivier, Romain Coriat, Marion Dhooge, et al.. (2012). Feasibility of gemcitabine and oxaliplatin in patients with advanced biliary tract carcinoma and a performance status of 2. Anti-Cancer Drugs. 23(7). 739–744. 17 indexed citations

12.

Dior, Marie, Romain Coriat, Olivier Mir, et al.. (2012). A Rare Hematological Adverse Event Induced by Bevacizumab: Severe Thrombocytopenia. The American Journal of Medicine. 125(8). 828–830. 13 indexed citations

13.

Dréanic, Johann, Romain Coriat, Olivier Mir, et al.. (2012). Cervical extravasation of bevacizumab. Anti-Cancer Drugs. 24(4). 426–428. 4 indexed citations

14.

Rubbia‐Brandt, Laura, Sébastien Tauzin, Catherine Brézault, et al.. (2011). Gene Expression Profiling Provides Insights into Pathways of Oxaliplatin-Related Sinusoidal Obstruction Syndrome in Humans. Molecular Cancer Therapeutics. 10(4). 687–696. 47 indexed citations

15.

Coriat, Romain, Géraldine Perkins, & Catherine Brézault. (2011). Incidence et physiopathologie de l’endobrachyœsophage. La Presse Médicale. 40(5). 496–501. 1 indexed citations

16.

Coriat, Romain, Olivier Mir, Anatole Cessot, et al.. (2010). Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patients. Investigational New Drugs. 30(1). 376–381. 20 indexed citations

17.

Gaudric, M, et al.. (2008). Pertinence des indications de la coloscopie dans un service de gastroentérologie de l'AP-HP en 2001. 15(3). 203–66. 3 indexed citations

18.

Rubbia‐Brandt, Laura, Emiliano Giostra, Catherine Brézault, et al.. (2006). Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Annals of Oncology. 18(2). 299–304. 374 indexed citations

19.

Peeters, Marc, Jean‐Luc Raoul, Jean‐Luc Van Laethem, et al.. (2005). Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in the first-line treatment of metastatic colorectal cancer (mCRC). Ghent University Academic Bibliography (Ghent University). 17 indexed citations

20.

Desrame, Jérôme, C Duvic, Dominique Béchade, et al.. (2004). Syndrome hémolytique et urémique secondaire à la gemcitabine : à propos de six observations et revue de la littérature. La Revue de Médecine Interne. 26(3). 179–188. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact